Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234

PURPOSE: To report results of a randomized phase II trial (Radiation Therapy Oncology Group RTOG-0234) examining concurrent chemoradiotherapy and cetuximab in the postoperative treatment of patients with squamous cell carcinoma of the head and neck (SCCHN) with high-risk pathologic features. PATIENT...

詳細記述

保存先:
書誌詳細
主要な著者: Harari, Paul M., Harris, Jonathan, Kies, Merrill S., Myers, Jeffrey N., Jordan, Richard C., Gillison, Maura L., Foote, Robert L., Machtay, Mitchell, Rotman, Marvin, Khuntia, Deepak, Straube, William, Zhang, Qiang, Ang, Kian
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2014
主題:
ORIGINAL REPORTS
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121506/
https://ncbi.nlm.nih.gov/pubmed/25002723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.53.9163
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料